Michèle Chevallier

3.3k total citations
41 papers, 2.6k citations indexed

About

Michèle Chevallier is a scholar working on Epidemiology, Hepatology and Infectious Diseases. According to data from OpenAlex, Michèle Chevallier has authored 41 papers receiving a total of 2.6k indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Epidemiology, 24 papers in Hepatology and 9 papers in Infectious Diseases. Recurrent topics in Michèle Chevallier's work include Hepatitis B Virus Studies (19 papers), Hepatitis C virus research (14 papers) and Liver Disease Diagnosis and Treatment (13 papers). Michèle Chevallier is often cited by papers focused on Hepatitis B Virus Studies (19 papers), Hepatitis C virus research (14 papers) and Liver Disease Diagnosis and Treatment (13 papers). Michèle Chevallier collaborates with scholars based in France, United States and Morocco. Michèle Chevallier's co-authors include Sylviane Guérret, Jean‐Alexis Grimaud, Fabien Zoulim, Christian Trépo, P. Chossegros, Christian Trépo, C. Trépo, Catherine Lemonnier, Pierre Pradat and Philippe Chevallier and has published in prestigious journals such as New England Journal of Medicine, Hepatology and Oncogene.

In The Last Decade

Michèle Chevallier

40 papers receiving 2.6k citations

Peers

Michèle Chevallier
Comparison fields: 5 of 108
  • Epidemiology 1.8k
  • Hepatology 1.8k
  • Molecular Biology 295
  • Infectious Diseases 273
  • Surgery 161
Tsunamasa Watanabe Japan
J. Tilman Gerlach Germany
Pui–Chee Wu Hong Kong
Riccardo Volpes Italy
Ming Shi China
Junliang Fu China
E. Walter Germany
Shogo Ohkoshi Japan
H Löhr Germany
Ming–Yang Lai Taiwan
Tsunamasa Watanabe Japan View profile →
Citations per field, relative to Michèle Chevallier
Michèle Chevallier · 1×
Citations per year, relative to Michèle Chevallier
Michèle Chevallier · 1×

Countries citing papers authored by Michèle Chevallier

Since Specialization
Citations

This map shows the geographic impact of Michèle Chevallier's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michèle Chevallier with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michèle Chevallier more than expected).

Fields of papers citing papers by Michèle Chevallier

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michèle Chevallier. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michèle Chevallier. The network helps show where Michèle Chevallier may publish in the future.

Co-authorship network of co-authors of Michèle Chevallier

This figure shows the co-authorship network connecting the top 25 collaborators of Michèle Chevallier. A scholar is included among the top collaborators of Michèle Chevallier based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michèle Chevallier. Michèle Chevallier is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
# Title Journal Authors Indexed citations
1 The role of nucleoside and nucleotide analogues in nodular regenerative hyperplasia in HIV-infected patients: A case control study Journal of Hepatology Laurent Cotte, Thomas Bénet et al. 32
2 Les méthodes d’épuration extra-rénale La Revue de l Infirmière Michèle Chevallier 0
3 Progression to cirrhosis in hepatitis C patients: an age‐dependent process Liver International Pierre Pradat, Nicolas Voirin et al. 67
4 Increase of doxorubicin sensitivity by doxorubicin-loading into nanoparticles for hepatocellular carcinoma cells in vitro and in vivo Journal of Hepatology Luc Barraud, Philippe Merle et al. 168
5 Histological response in patients treated by interferon plus ribavirin for hepatitis C virus-related severe fibrosis European Journal of Gastroenterology & Hepatology Armand Abergel, Claude Darcha et al. 26
6 Antiviral effect of adefovir in combination with a DNA vaccine in the duck hepatitis B virus infection model Journal of Hepatology Michèle Chevallier, Catherine Jamard et al. 39
7 Preliminary results of interferon-α therapy on woodchuck hepatitis virus-induced hepatocarcinogenesis: possible benefit in female transgenic mice Journal of Hepatology Philippe Merle, Michèle Chevallier et al. 17
8 High incidence of hepatitis B infections among chronic hepatitis cases of unknown aetiology Journal of Hepatology Isabelle Chemin, Fabien Zoulim et al. 141
9 Transglutaminase-mediated cross-linking is involved in the stabilization of extracellular matrix in human liver fibrosis Journal of Hepatology Pascale Grenard, Saı̈d El Alaoui et al. 133
10 Small Nodule Detection in Cirrhotic Livers: Evaluation with US, Spiral CT, and MRI and Correlation with Pathologic Examination of Explanted Liver Journal of Computer Assisted Tomography Agnès Rode, Brigitte Bancel et al. 213
11 Increased Expression of Growth Hormone and Prolactin Receptors in Hepatocellular Carcinomas Endocrine Tomás García‐Caballero, Anne-Sophie Lambert et al. 53
12 Liver injury due to tetrabamate (Atrium®) European Journal of Gastroenterology & Hepatology Jérôme Dumortier, B Bellemin et al. 5
13 Rapid detection of genotypes and mutations in the pre-core promoter and the pre-core region of hepatitis B virus genome: correlation with viral persistence and disease severity Journal of Hepatology Pierre Pradat, Lieven Stuyver et al. 191
14 Enhanced Duck Hepatitis B Virus Gene Expression Following Aflatoxin B Exposure Hepatology Luc Barraud, Sylviane Guérret et al. 23
15 Treatment of Hepatitis C Virus-Related Cirrhosis: A Randomized, Controlled Trial of Interferon Alfa–2B Versus No Treatment Hepatology Dominique Valla, Michèle Chevallier et al. 167
16 The carboxy-terminal cross-linked telopeptide of type I collagen (ICTP) is a potential serum marker of ongoing liver fibrosis Clinica Chimica Acta Sylvie Ricard‐Blum, P. Chossegros et al. 25
17 In situ detection of human cytomegalovirus DNA in gastrointestinal biopsies from AIDS patients by means of various PCR-derived methods Journal of Virological Methods Orlando Musso, Pascal Sommer et al. 17
18 A Comparison of Three Interferon Alfa-2b Regimens for the Long-Term Treatment of Chronic Non-A, Non-B Hepatitis New England Journal of Medicine Thierry Poynard, Pierre Bédossa et al. 379
19 Elastin in human, baboon, and mouse liver: An immunohistochemical and immunoelectron microscopic study The Anatomical Record Luís Cristóvão Pôrto, Michèle Chevallier et al. 19
20 Morphometry of terminal hepatic veins Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin Luís Cristóvão Pôrto, Michèle Chevallier et al. 15

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026